Billie Jean King and Novo Nordisk Offer Scholarships to Tennis Players with Diabetes
June 1st is the deadline to apply for one of two $5,000 scholarships to be awarded by Novo Nordisk to young tennis players who have diabetes. The winners will receive an expense paid trip to Philadelphia on July 5 to receive their award from Billie Jean King. June 1st Deadline for Scholarships for Tennis Players with Diabetes
(PRWEB) May 7, 2005 -- Two young people, ages 14-21, who have diabetes and play tennis competitively in tournaments or on their school team will receive a $5,000 scholarship from Novo Nordisk. In addition, the recipients will travel to Philadelphia to receive their awards from Billie Jean King at a World Team Tennis match featuring Martina Hingis on July 5, 2005. Billie Jean King established the awards in 1998 to encourage diabetic children to lead an active life and compete in tennis.
The winners for 2004 are Mitch Fender, 18, of Fernandina Beach, Florida, and Travis Fillmore of Tahlequah, Oklahoma. Fender was captain of his high school tennis and golf teams, and was an honor student despite having to give himself insulin injections three times per day. Fillmore wears an insulin pump to control his diabetes. He is ranked #47 in the nation in the 14-and-under age division, is an honor student, and has won awards in both art and science competitions.
All applications must be received by June 1, 2005, and the winners will be announced by June 15, 2005. For more information and to download an application log on to www.wtt.com and click on BJK/WTT Charities. Novo Nordisk, the leading pharmaceutical company in diabetes care, is proud to be the new sponsor of the Novo Nordisk Donnelly Awards.
For further information contact:
Anne Guerrant, Executive Director
Billie Jean King WTT Charities, Inc
aguerrant@wtt.com
# # #
Bookmark -
Del.icio.us |
Furl It |
Technorati |
Ask |
MyWeb |
Propeller |
Live Bookmarks |
Newsvine |
TailRank |
Reddit |
Slashdot |
Digg |
Stumbleupon |
Google Bookmarks |
Sphere |
Blink It |
Spurl
|
